Mark E. Bubak

528 total citations
11 papers, 387 citations indexed

About

Mark E. Bubak is a scholar working on Dermatology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Mark E. Bubak has authored 11 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Dermatology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Mark E. Bubak's work include Renal Transplantation Outcomes and Treatments (2 papers), Chemical Safety and Risk Management (2 papers) and Allergic Rhinitis and Sensitization (2 papers). Mark E. Bubak is often cited by papers focused on Renal Transplantation Outcomes and Treatments (2 papers), Chemical Safety and Risk Management (2 papers) and Allergic Rhinitis and Sensitization (2 papers). Mark E. Bubak collaborates with scholars based in United States and Slovenia. Mark E. Bubak's co-authors include John W. Yunginger, Loren W. Hunt, Charles E. Reed, Mark C. Swanson, Mark A. Warner, Ruud A. F. Krom, Michael K. Porayko, Russell H. Wiesner, Anthony F. Fransway and Mark A. Moyad and has published in prestigious journals such as Hepatology, Journal of Allergy and Clinical Immunology and Mayo Clinic Proceedings.

In The Last Decade

Mark E. Bubak

11 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Bubak United States	7	198	123	100	69	56	11	387
C. P. SANDIFORD United Kingdom	11	170 0.9×	307 2.5×	171 1.7×	22 0.3×		15	544
Bogdan Petrunov Bulgaria	9	35 0.2×	19 0.2×	68 0.7×	14 0.2×	12 0.2×	25	196
I Zoellner Germany	6	133 0.7×	50 0.4×	29 0.3×	15 0.2×	48 0.9×	7	460
Mongkol Lao‐Araya Thailand	11	96 0.5×	14 0.1×	213 2.1×	47 0.7×	35 0.6×	30	380
Marcel A. Schijf Netherlands	12	90 0.5×	111 0.9×	46 0.5×	21 0.3×		20	398
C. Aparicio France	6	58 0.3×	36 0.3×	112 1.1×	18 0.3×	8 0.1×	10	219
Aderbal Sabrá Brazil	8	23 0.1×	19 0.2×	86 0.9×	80 1.2×	7 0.1×	23	262
Paul Stevenson United Kingdom	10	42 0.2×	39 0.3×	21 0.2×	91 1.3×	7 0.1×	10	392
Hossein Ali Khazaei Iran	9	21 0.1×	25 0.2×	47 0.5×	42 0.6×	4 0.1×	31	294
W.G.L. Allan United Kingdom	10	50 0.3×	10 0.1×	122 1.2×	63 0.9×	6 0.1×	18	409

Countries citing papers authored by Mark E. Bubak

Since Specialization

Citations

This map shows the geographic impact of Mark E. Bubak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Bubak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Bubak more than expected).

Fields of papers citing papers by Mark E. Bubak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Bubak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Bubak. The network helps show where Mark E. Bubak may publish in the future.

Co-authorship network of co-authors of Mark E. Bubak

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Bubak. A scholar is included among the top collaborators of Mark E. Bubak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Bubak. Mark E. Bubak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Bubak, Mark E., et al.. (2019). Outcomes of Simulated Use of Epinephrine Injection USP Auto-injectors. Journal of Allergy and Clinical Immunology. 143(2). AB153–AB153. 1 indexed citations

2.

Moyad, Mark A., Larry E. Robinson, Julie M. Kittelsrud, et al.. (2009). Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Advances in Therapy. 26(8). 795–804. 31 indexed citations

3.

Bubak, Mark E., et al.. (2009). The impact of secondhand smoke on children: respiratory and other medical concerns.. PubMed. Spec No. 13–6. 4 indexed citations

4.

Bubak, Mark E., et al.. (2000). 250 Natural rubber latex skin test safety. Journal of Allergy and Clinical Immunology. 105(1). S83–S83. 2 indexed citations

5.

Bubak, Mark E.. (2000). Expert Guide to Allergy and Immunology. Mayo Clinic Proceedings. 75(3). 320–320. 1 indexed citations

6.

Bubak, Mark E.. (2000). Expert Guide to Allergy and Immunology. Mayo Clinic Proceedings. 75(3). 320–320. 9 indexed citations

7.

Swanson, Mark C., Mark E. Bubak, Loren W. Hunt, et al.. (1994). Quantification of occupational latex aeroallergens in a medical center. Journal of Allergy and Clinical Immunology. 94(3). 445–451. 150 indexed citations

8.

Bubak, Mark E., et al.. (1992). Allergic Reactions to Latex Among Health-Care Workers. Mayo Clinic Proceedings. 67(11). 1075–1079. 91 indexed citations

9.

Bubak, Mark E., Michael K. Porayko, Ruud A. F. Krom, & Russell H. Wiesner. (1991). Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy. Hepatology. 14(6). 1063–1065. 68 indexed citations

10.

Bubak, Mark E.. (1991). Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy. Hepatology. 14(6). 1063–1065. 10 indexed citations

11.

Reed, C.E., et al.. (1991). Ragweed-Specific IgA in Nasal Lavage Fluid of Ragweed-Sensitive Allergic Rhinitis Patients: Increase during the Pollen Season. International Archives of Allergy and Immunology. 94(1-4). 275–277. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact